Longboard Pharmaceuticals, Inc. (LBPH) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts LBPH Hot Sheet
Join SI Premium – FREE
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.63), $0.05 worse than the analyst estimate of ($0.58).
For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
